Colgate-Palmolive(CL)
Search documents
Colgate-Palmolive Dividend Scorecard: How Does the 2.6% Yield Stack Up?
247Wallst· 2026-02-12 17:42
Colgate-Palmolive Dividend Scorecard: How Does the 2.6% Yield Stack Up? - 24/7 Wall St.[S&P 5006,875.70 -1.08%][Dow Jones49,614.20 -1.06%][Nasdaq 10024,830.20 -1.54%][Russell 20002,620.39 -1.97%][FTSE 10010,411.70 -1.04%][Nikkei 22557,016.70 -2.04%][Live Nasdaq Composite: Tech Stock Volatility Persists on Mixed Economic Signals][Investing]# Colgate-Palmolive Dividend Scorecard: How Does the 2.6% Yield Stack Up?### Quick ReadColgate-Palmolive (CL) paid $0.52 per share on February 13, extending its 63-year di ...
BJ or CL: Which Is the Better Value Stock Right Now?
ZACKS· 2026-02-10 17:40
Investors interested in Consumer Products - Staples stocks are likely familiar with BJ's Wholesale Club (BJ) and Colgate-Palmolive (CL) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, ...
Consumer Staples Look Pricey. Consider Clorox and Other High Yielders With Solid Dividends.
Barrons· 2026-02-09 19:10
Consumer Staples Look Pricey. Consider Clorox and Other High Yielders With Solid Dividends. - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Consumer Staples Look Pricey. Consider Clorox and Other High Yielders With Solid Dividends.By [Paul ...
Colgate (CL) Is Consistent, Says Jim Cramer
Yahoo Finance· 2026-02-07 15:08
We recently published 12 Stocks Jim Cramer Talked About. Colgate-Palmolive Company (NYSE:CL) is one of the stocks that Jim Cramer talked about. Colgate-Palmolive Company (NYSE:CL) is a well-known global oral and personal care brand. Its shares are up by 10.5% over the past year and by 22% year-to-date. Multiple analysts have discussed the stock so far in 2026. For instance, Morgan Stanley raised the share price target to $100 from $87 and kept an Overweight rating on Colgate-Palmolive Company (NYSE:CL)’s ...
Colgate-Palmolive: A Much-Needed Shelter For Returns In 2026
Seeking Alpha· 2026-02-05 21:27
Vladimir Dimitrov, CFA is a former strategy consultant within the field of brand and intangible assets valuation. During his career in the City of London he has been working with some of the largest global brands within the technology, telecom and banking sectors. He graduated from the London School of Economics and is interested in finding reasonably priced businesses with sustainable long-term competitive advantages.Analyst’s Disclosure: I/we have a beneficial long position in the shares of UL either thro ...
Barclays Lifts Colgate (CL) Target as 2026 Growth Outlook Improves
Yahoo Finance· 2026-02-05 19:18
Colgate-Palmolive Company (NYSE:CL) is included among the 15 Best Wide Moat Dividend Stocks to Invest in. Barclays Lifts Colgate (CL) Target as 2026 Growth Outlook Improves On February 3, Barclays analyst Lauren Lieberman raised the price recommendation on Colgate-Palmolive Company (NYSE:CL) to $88 from $83. The firm kept an Equal Weight rating. The analyst said in the research note that growth in 2026 should look better than 2025, but the company likely won’t get the same lift from inflation-driven pric ...
Colgate-Palmolive: Still A Buy As The 2030 Growth Strategy Begins (NYSE:CL)
Seeking Alpha· 2026-02-04 18:43
Core Insights - The analyst has over a decade of experience researching various industries, including commodities like oil, natural gas, gold, and copper, as well as technology companies such as Google and Nokia, and emerging market stocks [1] Group 1: Company Focus - The analyst has a particular interest in covering metals and mining stocks, while also being comfortable with other sectors such as consumer discretionary, consumer staples, REITs, and utilities [1]
Colgate-Palmolive: Still A Buy As The 2030 Growth Strategy Begins
Seeking Alpha· 2026-02-04 18:43
Core Insights - The analyst has over a decade of experience researching various industries, including commodities like oil, natural gas, gold, and copper, as well as technology companies such as Google and Nokia, and emerging market stocks [1] Group 1: Company Focus - The analyst has a particular interest in covering metals and mining stocks, while also being comfortable with other sectors like consumer discretionary/staples, REITs, and utilities [1] Group 2: Research Methodology - The analyst has transitioned from writing a blog to creating a value investing-focused YouTube channel, where extensive research on hundreds of companies has been conducted [1]
This Once-Sleepy Consumer Staples Stock Is Beating the S&P 500 by 8-to-1 in 2026: Should You Buy?
Yahoo Finance· 2026-02-03 23:44
Core Insights - Colgate-Palmolive has shown a total return of 379% over the past 25 years, with a 533% increase in dividends during the same period, but has underperformed the S&P 500's 539% return [1][2] - In 2026, the stock has risen 16.8%, significantly outperforming the S&P 500's 2.1% increase, leading to speculation about continued momentum [2] Financial Performance - The company's fourth-quarter earnings report revealed a 5.8% year-over-year increase in sales, totaling $5.23 billion, primarily driven by price increases rather than volume growth [3] - Organic sales grew by 2.2%, indicating some growth from existing operations [3] - Despite a reported net loss of $5 million due to a $794 million impairment charge in the skin-health segment, adjusted earnings would have been $0.95 per share, surpassing analyst expectations of $0.91 [4] Market Outlook - Management provided a sales growth outlook of 2% to 6% for the upcoming year, slightly above the 3% expected by analysts [5] - Analysts have consistently underestimated Colgate-Palmolive's sales in the past four quarters, suggesting potential for future surprises [6] Valuation Concerns - The stock's recent price surge has resulted in a price-to-earnings ratio exceeding 34, compared to the S&P 500 average of 29.5, raising concerns about valuation [8] - Earnings growth from January 2022 to January 2025 was only 12.3%, translating to an annualized growth rate of just over 4%, which may not justify the current valuation [8]
Colgate-Palmolive Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Colgate-Palmolive (NYSE:CL)
Benzinga· 2026-02-02 17:19
Colgate-Palmolive Company (NYSE:CL) posted better-than-expected fourth-quarter earnings on Friday.The company reported fourth-quarter adjusted earnings per share of 95 cents, beating the analyst consensus estimate of 91 cents. Quarterly sales of $5.230 billion, beating the Street view of $5.118 billion."Net sales and organic sales grew in every category during the quarter, led by strength in oral care and pet nutrition, excluding private label," said CEO Noel Wallace.Colgate-Palmolive forecasts fiscal 2026 ...